Standard BioTools Ownership | Who Owns Standard BioTools?
Standard BioTools Ownership Summary
Standard BioTools is owned by 75.47% institutional investors, 1.93% insiders, and 22.60% retail investors. Casdin capital is the largest institutional shareholder, holding 17.18% of LAB shares.
LAB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Standard BioTools | 75.47% | 1.93% | 22.60% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Diagnostics & Research Stocks | 52.07% | 8.42% | 39.50% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Casdin capital | 63.96M | 17.18% | $113.21M |
| Viking global investors lp | 58.65M | 15.75% | $103.81M |
| Blackrock | 21.75M | 5.84% | $38.50M |
| Vanguard group | 16.00M | 4.30% | $28.33M |
| Morgan stanley | 12.93M | 3.47% | $22.89M |
| Ark investment management | 12.68M | 3.41% | $22.44M |
| Sumitomo mitsui trust | 10.64M | 2.86% | $18.84M |
| Nikko asset management americas | 10.64M | 2.86% | $18.73M |
| Geode capital management | 6.79M | 1.82% | $12.03M |
| Tikvah management | 6.55M | 1.76% | $11.60M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Casdin capital | 63.96M | 8.64% | $113.21M |
| Tikvah management | 6.55M | 3.78% | $11.60M |
| Nan fung group | 1.88M | 3.56% | $3.33M |
| Price jennifer c. | 980.10K | 2.02% | $1.73M |
| Viking global investors lp | 58.65M | 0.40% | $103.81M |
| Gagnon securities | 898.51K | 0.36% | $1.59M |
| Bradley & co. private wealth management | 223.94K | 0.29% | $396.37K |
| Nikko asset management americas | 10.64M | 0.22% | $18.73M |
| Intellectus partners | 419.70K | 0.20% | $742.87K |
| Ark investment management | 12.68M | 0.20% | $22.44M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 21.75M | 0.00% | 16.30M |
| Morgan stanley | 12.93M | 0.00% | 5.32M |
| Geode capital management | 6.79M | 0.00% | 4.09M |
| State street | 4.34M | 0.00% | 3.00M |
| Vanguard group | 16.00M | 0.00% | 2.97M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Millennium management | 6.22M | 0.01% | -8.15M |
| Indaba capital management | - | - | -7.36M |
| Balyasny asset management | 998.16K | 0.00% | -3.85M |
| Goldman sachs group | 640.98K | 0.00% | -2.64M |
| Parkman healthcare partners | - | - | -1.67M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Nuveen asset management | 783.15K | 0.00% | 783.15K | $1.39M |
| Shaolin capital management | 330.00K | 0.02% | 330.00K | $584.10M |
| Alliancebernstein | 315.69K | 0.00% | 315.69K | $558.77K |
| Royce & associates lp | 304.23K | 0.01% | 304.23K | $538.49K |
| Corebridge financial | 162.31K | 0.00% | 162.31K | $288.92K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -31.00 |
| Wolverine asset management | -100.00 |
| Newedge advisors | -300.00 |
| Vanguard personalized indexing management | -11.03K |
| Ground swell capital | -12.05K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 142 | -3.40% | 280,390,521 | 3.64% | 75 | 1.43% | 61 | -17.57% | 44 | 25.71% |
| Jun 30, 2024 | 147 | - | 270,549,608 | 1.97% | 72 | 0.89% | 74 | -38.33% | 35 | 169.23% |
| Mar 31, 2024 | 147 | 72.94% | 265,333,556 | 446.77% | 90 | 33.14% | 120 | 144.90% | 13 | -18.75% |
| Dec 31, 2023 | 85 | 14.86% | 48,527,129 | 2.38% | 16 | 6.35% | 49 | 63.33% | 16 | -20.00% |
| Sep 30, 2023 | 74 | 12.12% | 47,399,344 | 2.76% | 16 | 6.55% | 30 | 25.00% | 20 | -16.67% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 27, 2024 | Casdin Partners Master Fund, L.P. | Buy | $546.75K | |
| Aug 23, 2024 | Casdin Partners Master Fund, L.P. | Buy | $620.98K | |
| Aug 26, 2024 | Casdin Partners Master Fund, L.P. | Buy | $322.45K | |
| Aug 22, 2024 | Casdin Partners Master Fund, L.P. | Buy | $602.81K | |
| Aug 21, 2024 | Casdin Partners Master Fund, L.P. | Buy | $951.95K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | - |
| 2024 Q3 | 15 | - |
| 2024 Q2 | 7 | - |
| 2024 Q1 | 2 | - |
| 2023 Q4 | - | - |
LAB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools